Returned Target Sample Clauses

Returned Target. If, prior to a Compound being designated a Development Compound, Bayer or CuraGen learns or discovers that the use of the related Screened Qualified Target infringes one or more claims of an issued patent in the country in which the use of such Screened Qualified Target is expected to occur and such Screened Qualified Target has not reverted to CuraGen pursuant to Section 3.7(c), then Bayer shall have the right to return such Screened Qualified Target to CuraGen and that Screened Qualified Target shall no longer count as a Screened Qualified Target which CuraGen is obligated to deliver hereunder.